A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

BACKGROUND: In many countries worldwide, the long-acting anticholinergic drug tiotropium is available as a dry powder formulation delivered by means of the HandiHaler® inhalation device and as an aqueous solution delivered via the Respimat® Soft Mist™ Inhaler. Tiotropium HandiHaler® is a single-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahl, Ronald, Kaplan, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057252/
https://www.ncbi.nlm.nih.gov/pubmed/27724909
http://dx.doi.org/10.1186/s12890-016-0291-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057252/
https://www.ncbi.nlm.nih.gov/pubmed/27724909
http://dx.doi.org/10.1186/s12890-016-0291-4

Ejemplares similares